Here are three things to know.
1. The organizations will use Optum’s claims and clinical records data to create and assess valued-based prescription payment models.
2. Optum and Merck will publicly share their assessments of the payment models “to help inform and facilitate the understanding and use of pragmatic approaches to [outcomes-based risk sharing agreements] in the healthcare system.
3. The partnership is the latest in a growing number of valued-based reimbursement collaborations for prescription drug payments.
- Bloomfield, Con.-based Cigna has entered seven outcomes-based deals since 2009, according to Bloomberg.
- Danish drugmaker Novo Nordisk recently signed its first pay-for-performance contract with Louisville, Ky.-based Humana for the diabetes treatment Victoza.
- Novartis, Amgen, Sanofi and Eli Lilly & Co., have also signed similar contracts with various insurers in the past year, according to the report.
More articles on payer issues:
7 questions about UnitedHealth’s false claims lawsuits, answered
How Aetna, Anthem, Humana and UnitedHealth fared in Q1
CMS seeks to remove small business plan enrollment from ACA marketplace: 3 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
